WuXi AppTec completes acquisition of AAV manufacturer Oxgene

Since its founding in 2011, Oxgene has offered discovery and biomanufacturing solutions to the cell and gene therapy industries through novel technologies and contract research solutions

picture of

Breaking News

Cell-based therapy specialist Solentim expands European operations

The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within ...

Catalent acquires third facility in Belgium for pDNA manufacturing

CDMO Catalent has acquired liver disease specialist Promethera's cell therapy manufacturing subsidiary, including its ...

German CDMO to spend $84m expanding biological cGMP space

Richter-Helm BioLogics has received investment for the new multi-product biological manufacturing facility that is ...

Bispecific antibodies in review: from cell line development to manufacturing

With the advent of a technology that targets two different epitopes simultaneously, growth in the global bispecific ...

Enesi Pharma hits milestone in thermostable solid-dose live vaccines development

Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella

Thermo Fisher launches first cleanroom-compatible CO2 incubator for cell culture

Thermo Fisher has designed the cell growth incubator with in-chamber HEPA filtration, on-demand 180°C sterilisation ...

Lessons learned from the COVID-19 pandemic

As vaccines roll out and COVID-19 cases begin to decline, Amélie Boulais, Head of Market Entry Strategy for Virus ...

Sartorius to open manufacturing facility in Hampshire

With the Havant facility, Sartorius now has five locations in the UK, employing over 900 staff members

Moderna and Catalent announce expanded vaccine collaboration

In September 2020, Catalent announced a $50 m investment into the third high-speed vial filling line at Bloomington. ...

Bispecific antibodies: an exciting new class of emerging therapeutics

Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...

From dark art to an age of enlightenment

Much is happening in the realms of Almac’s GMP peptides business in terms of growth, development and strategic ...

Why the production of bispecific antibodies depends on early stage product characterisation

Chloe Ackaert, Senior Scientist, and Sofie Pattijn, Chief Technology Officer and founder, ImmunXperts a Nexelis group ...

Azzur completes second ready-to-use cleanroom facility in San Diego

US-based Azzur Cleanrooms on Demand has announced the completion of a build in San Diego that is the group's second ...

Chime Biologics announces $190m funds to accelerate capacity expansion

The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 ...